164 related articles for article (PubMed ID: 31584650)
1. Nutritional strategies to modulate inflammation pathways via regulation of peroxisome proliferator-activated receptor β/δ.
da Cruz BO; Cardozo LFMF; Magliano DC; Stockler-Pinto MB
Nutr Rev; 2020 Mar; 78(3):207-214. PubMed ID: 31584650
[TBL] [Abstract][Full Text] [Related]
2. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
[TBL] [Abstract][Full Text] [Related]
3. Nrf2, NF-κB and PPARβ/δ mRNA Expression Profile in Patients with Coronary Artery Disease.
Barbosa JE; Stockler-Pinto MB; Cruz BOD; Silva ACTD; Anjos JS; Mesquita CT; Mafra D; Cardozo LFMF
Arq Bras Cardiol; 2019 Dec; 113(6):1121-1127. PubMed ID: 31340238
[TBL] [Abstract][Full Text] [Related]
4. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
[TBL] [Abstract][Full Text] [Related]
5. Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells.
Thulasiraman P; McAndrews DJ; Mohiudddin IQ
BMC Cancer; 2014 Sep; 14():724. PubMed ID: 25260874
[TBL] [Abstract][Full Text] [Related]
6. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.
Alvarez-Guardia D; Palomer X; Coll T; Serrano L; Rodríguez-Calvo R; Davidson MM; Merlos M; El Kochairi I; Michalik L; Wahli W; Vázquez-Carrera M
Biochim Biophys Acta; 2011 Feb; 1811(2):59-67. PubMed ID: 21070867
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.
Bishop-Bailey D; Bystrom J
Pharmacol Ther; 2009 Nov; 124(2):141-50. PubMed ID: 19615407
[TBL] [Abstract][Full Text] [Related]
8. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor.
Berry DC; Noy N
Mol Cell Biol; 2009 Jun; 29(12):3286-96. PubMed ID: 19364826
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
10. Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease.
Vázquez-Carrera M
Trends Endocrinol Metab; 2016 May; 27(5):319-334. PubMed ID: 27005447
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
Yao PL; Chen L; Dobrzański TP; Zhu B; Kang BH; Müller R; Gonzalez FJ; Peters JM
Mol Carcinog; 2017 May; 56(5):1472-1483. PubMed ID: 27996177
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy.
Planavila A; Laguna JC; Vázquez-Carrera M
J Biol Chem; 2005 Apr; 280(17):17464-71. PubMed ID: 15728586
[TBL] [Abstract][Full Text] [Related]
13. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta.
Degenhardt T; Saramäki A; Malinen M; Rieck M; Väisänen S; Huotari A; Herzig KH; Müller R; Carlberg C
J Mol Biol; 2007 Sep; 372(2):341-55. PubMed ID: 17669420
[TBL] [Abstract][Full Text] [Related]
14. Establishing the Role of PPARβ/δ in Carcinogenesis.
Peters JM; Gonzalez FJ; Müller R
Trends Endocrinol Metab; 2015 Nov; 26(11):595-607. PubMed ID: 26490384
[TBL] [Abstract][Full Text] [Related]
15. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
Wagner KD; Wagner N
Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
[TBL] [Abstract][Full Text] [Related]
17. Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.
Peters JM; Kim DJ; Bility MT; Borland MG; Zhu B; Gonzalez FJ
Mol Carcinog; 2019 Sep; 58(9):1612-1622. PubMed ID: 31062422
[TBL] [Abstract][Full Text] [Related]
18. PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders.
Palomer X; Barroso E; Pizarro-Delgado J; Peña L; Botteri G; Zarei M; Aguilar D; Montori-Grau M; Vázquez-Carrera M
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29558390
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-β/δ modulates mast cell phenotype.
Yao PL; Morales JL; Gonzalez FJ; Peters JM
Immunology; 2017 Apr; 150(4):456-467. PubMed ID: 27935639
[TBL] [Abstract][Full Text] [Related]
20. TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes.
Serrano-Marco L; Chacón MR; Maymó-Masip E; Barroso E; Salvadó L; Wabitsch M; Garrido-Sánchez L; Tinahones FJ; Palomer X; Vendrell J; Vázquez-Carrera M
Biochim Biophys Acta; 2012 Sep; 1821(9):1177-85. PubMed ID: 22683888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
